The European Union’s drug regulator is probing a possible link between diabetes drugs, popular for weight loss, and suicidal thoughts.
The European Medicines Agency (EMA) is assessing 150 reports of possible cases of self-injury among people taking a class of medications called GLP-1 agonists, which play a role in regulating metabolism and hunger.
